Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter M Dull

Showing results (11-20 of 48) with videos related to

Pageof 5
Sort By:
Vaccine|March 7, 2015
Antibody persistence 5 years after vaccination at 2 to 10 years of age with Quadrivalent MenACWY-CRM conjugate vaccine, and responses to a booster vaccinationStan L Block, Shane Christensen, Bikash Verma, et al.
The Pediatric Infectious Disease Journal|June 10, 2014
Antibody persistence after primary and booster doses of a quadrivalent meningococcal conjugate vaccine in adolescentsRoger Baxter, Keith Reisinger, Stanley L Block, et al.
Human Vaccines & Immunotherapeutics|November 27, 2014
A phase 2 randomized controlled trial of a multicomponent meningococcal serogroup B vaccine, 4CMenB, in infants (II)Susanna Esposito, Roman Prymula, Gian Vincenzo Zuccotti, et al.
Human Vaccines & Immunotherapeutics|November 27, 2014
A phase 2 randomized controlled trial of a multicomponent meningococcal serogroup B vaccine (I)Roman Prymula, Susanna Esposito, Gian Vincenzo Zuccotti, et al.
The Pediatric Infectious Disease Journal|October 20, 2015
Immunogenicity and Safety of a 3- and 4-dose Vaccination Series of a Meningococcal ACWY Conjugate Vaccine in Infants: Results of a Phase 3b, Randomized, Open-label TrialStan L Block, Julie Shepard, Hartley Garfield, et al.
The Pediatric Infectious Disease Journal|January 1, 2009
A randomized trial to determine the tolerability and immunogenicity of a quadrivalent meningococcal glycoconjugate vaccine in healthy adolescentsLisa A Jackson, Robert M Jacobson, Keith S Reisinger, et al.
Vaccine|March 22, 2015
A comparative evaluation of two investigational meningococcal ABCWY vaccine formulations: Results of a phase 2 randomized, controlled trialStan L Block, Leszek Szenborn, Wendy Daly, et al.
Vaccine|August 27, 2013
Considerations for a phase-III trial to evaluate a group B Streptococcus polysaccharide-protein conjugate vaccine in pregnant women for the prevention of early- and late-onset invasive disease in young-infantsShabir A Madhi, Ziyaad Dangor, Paul T Heath, et al.
Human Vaccines & Immunotherapeutics|November 14, 2013
Immunogenicity and safety of a CRM-conjugated meningococcal ACWY vaccine administered concomitantly with routine vaccines starting at 2 months of ageTerry M Nolan, Michael D Nissen, Aftab Naz, et al.
Human Vaccines & Immunotherapeutics|May 14, 2015
Immunogenicity and safety of investigational vaccine formulations against meningococcal serogroups A, B, C, W, and Y in healthy adolescentsXavier Saez-Llorens, Diana Catalina Aguilera Vaca, Katia Abarca, et al.
Pageof 5

Showing results (11-20 of 48) with videos related to

Sort By:
Pageof 5
Vaccine|March 7, 2015
Antibody persistence 5 years after vaccination at 2 to 10 years of age with Quadrivalent MenACWY-CRM conjugate vaccine, and responses to a booster vaccinationStan L Block, Shane Christensen, Bikash Verma, et al.
The Pediatric Infectious Disease Journal|June 10, 2014
Antibody persistence after primary and booster doses of a quadrivalent meningococcal conjugate vaccine in adolescentsRoger Baxter, Keith Reisinger, Stanley L Block, et al.
Human Vaccines & Immunotherapeutics|November 27, 2014
A phase 2 randomized controlled trial of a multicomponent meningococcal serogroup B vaccine, 4CMenB, in infants (II)Susanna Esposito, Roman Prymula, Gian Vincenzo Zuccotti, et al.
Human Vaccines & Immunotherapeutics|November 27, 2014
A phase 2 randomized controlled trial of a multicomponent meningococcal serogroup B vaccine (I)Roman Prymula, Susanna Esposito, Gian Vincenzo Zuccotti, et al.
The Pediatric Infectious Disease Journal|October 20, 2015
Immunogenicity and Safety of a 3- and 4-dose Vaccination Series of a Meningococcal ACWY Conjugate Vaccine in Infants: Results of a Phase 3b, Randomized, Open-label TrialStan L Block, Julie Shepard, Hartley Garfield, et al.
The Pediatric Infectious Disease Journal|January 1, 2009
A randomized trial to determine the tolerability and immunogenicity of a quadrivalent meningococcal glycoconjugate vaccine in healthy adolescentsLisa A Jackson, Robert M Jacobson, Keith S Reisinger, et al.
Vaccine|March 22, 2015
A comparative evaluation of two investigational meningococcal ABCWY vaccine formulations: Results of a phase 2 randomized, controlled trialStan L Block, Leszek Szenborn, Wendy Daly, et al.
Vaccine|August 27, 2013
Considerations for a phase-III trial to evaluate a group B Streptococcus polysaccharide-protein conjugate vaccine in pregnant women for the prevention of early- and late-onset invasive disease in young-infantsShabir A Madhi, Ziyaad Dangor, Paul T Heath, et al.
Human Vaccines & Immunotherapeutics|November 14, 2013
Immunogenicity and safety of a CRM-conjugated meningococcal ACWY vaccine administered concomitantly with routine vaccines starting at 2 months of ageTerry M Nolan, Michael D Nissen, Aftab Naz, et al.
Human Vaccines & Immunotherapeutics|May 14, 2015
Immunogenicity and safety of investigational vaccine formulations against meningococcal serogroups A, B, C, W, and Y in healthy adolescentsXavier Saez-Llorens, Diana Catalina Aguilera Vaca, Katia Abarca, et al.
Pageof 5